Conifex Timber Inc. ('Conifex”, 'we” or 'us”) (TSX: CFF) today reported results for the third quarter ended September 30, ...

Whether infection of cells by individual virions occurs randomly or if there is some form (s) of competition or cooperativity between individual virions remains largely unknown for most virus-cell ...

Third Quarter Net Sales and Adjusted EBITDA Exceeded Guidance Driven by 44% OEM Growth Gross Margin Expanded 710 Basis Points Year-over-Year ...

“During our third quarter of 2025, we continued to position the Company to advance IKT-001 toward a late-stage clinical trial in PAH,” said Mark Iwicki, Chief Executive Officer of Inhibikase. “We ...

Introduction European valvular heart disease guidelines define women as a ‘special group’. To explore what factors have led ...

Third Quarter Net Sales and Adjusted EBITDA Exceeded Guidance Driven by 44% OEM GrowthGross Margin Expanded 710 Basis Points Year-over-YearRecent Public Offerings and Debt Restructuring Significantly ...

Lifeward Ltd., (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global leader in innovative medical technology to transform the lives of people with physical limitations or disabilities, today ...

Background Hypothyroidism has been suggested as a predisposing and prognostic factor in patients with spontaneous coronary ...